Clinical trials image

A call for harmony on clinical trials

July 1, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frédéric Sgard, OECD, clinical trials

Clinical trials are an essential part of the development of medical treatments. They involve testing new medicines or new therapies, …

New chair for the BioIndustry Association

July 1, 2013

The BioIndustry Association has appointed Dr Edward Hodgkin as its new chairman, effective from October this year.Hodgkin succeeds Tim Edwards, …

Lords image

Lords: ‘Simplify pharma regulation’

July 1, 2013
Sales and Marketing Lords, NICE, pharma, regulation

Investors are not putting their money into the UK’s regenerative medicine sector because of the high failure rate when it …

IVF image

‘Three-person’ IVF consultation

June 28, 2013
Research and Development, Sales and Marketing DoH, HFEA, IVF

The Department of Health is to publish draft guidelines later this year on a controversial IVF-based technique which would lead …

Digital marketing image

Survey: ‘Consultants prefer mailshots’

June 28, 2013
Medical Communications, Sales and Marketing Onyx, digital, mailshots

Pharma should use standard marketing activities such as mailshots if they want to promote their products effectively in UK secondary …

Vaccine image

Diabetes vaccine trial posts positive results

June 28, 2013
Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes

A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …

kirsty_pmlive

Life appoints new account manager

June 28, 2013
Medical Communications, Research and Development, Sales and Marketing Life, mead

Creative comms agency Life has expanded its client service team with the appointment of a new account manager.Kirsty Mead joins Life from Seven …

Heparin image

FDA issues final guidance on heparin testing

June 27, 2013
Manufacturing and Production, Sales and Marketing FDA, heparin

Five years after the adulterated heparin scandal that claimed the lives of dozens of people in the US alone, the …

ImmTAC deal for Immunocore

June 27, 2013
Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech

Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …

bryan_morton

Oxford BioTherapeutics hires chairman

June 27, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics, morton

Biotech firm Oxford BioTherapeutics has appointed Bryan Morton to be the company’s new non-executive chairman. Morton has over 30 years’ …

Contract research news in brief

June 27, 2013
Research and Development PRA International, Parexel, Quanticate, TKL, WIL Research

A round-up of recent developments in the contract research sector, including KKR’s acquisition of PRA, a new Parexel business unit …

Cytokinetics image

Astellas in $500m deal with Cytokinetics

June 27, 2013
Sales and Marketing Astellas, cytokinetics

Astellas Pharma could pay out $40 million over the next two years to US firm Cytokinetics as part of a …

Heart failure treatment given Breakthrough Status

June 27, 2013
Sales and Marketing Breakthrough Therapy Designation, Novartis, RLX03O, serelaxin

Novartis’ new treatment for heart failure has been granted Breakthrough Therapy designation status by the FDA. RLX030 (serelaxin) is for …

Xtandi gets EU approval

June 26, 2013
Sales and Marketing Astellas, FDA, Xtandi

Astellas Pharma’s Xtandi has been approved in the European Union for the treatment of adult men with advanced prostate cancer, …

evista image

NICE finalises tamoxifen guidance

June 26, 2013
Sales and Marketing Evista, NICE, lilly, tamoxifen

Women at risk of breast cancer can now be offered a daily pill on the NHS to stop the disease …

douglas_ingram_allergan

Allergan announces new president

June 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, ingram

Allergan has hired Douglas Ingram to be its president and lead the company’s global commercial operations. In this newly established …

Sanofi image

Sanofi chief executive to lead EFPIA

June 26, 2013
Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …

Ranbaxy image

Ranbaxy facing another facility problem?

June 26, 2013
Manufacturing and Production FDA, Ranbaxy

Another facility operated by Ranbaxy Laboratories in India is reported to have failed an inspection by the FDA, potentially adding …

Forxiga image

NICE completes Forxiga U-turn

June 26, 2013
Sales and Marketing BMS, Forxiga, NICE

Bristol-Myers Squibb and AstraZeneca are celebrating after NICE reversed its decision from earlier this year and is now recommending their …

Merck Serono image

Merck Serono censured over calls

June 25, 2013
Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA

A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …

The Gateway to Local Adoption Series

Latest content